Rhinovirus Challenge in Asthmatics and Healthy Volunteers to Evaluate the Safety and Appropriate Dose of a GMP Human Rhinovirus 16 Preparation for Challenge Studies in Mild-Moderate Asthmatics taking ICS

Source: International Congress 2018 – Studies on the mechanisms underlying airway disease

Session: Studies on the mechanisms underlying airway disease
Session type: Thematic Poster
Number: 4406

Disease area: Airway diseases



Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Krug (Hannover, Germany), J. Hohlfeld (Hannover, Germany), A. Aliprantis (Kenilworth, New Jersey, United States of America), L. Carayannopoulos (Kenilworth, New Jersey, United States of America), A. Bautmans (Brussels, Belgium), M. Robberechts (Brussels, Belgium), I. De Lepeleire (Brussels, Belgium), H. Ziehr (Braunschweig, Germany), D. Singh (Manchester, United Kingdom), Z. Diamant (Lund, Sweden), S. Yang (Kenilworth, New Jersey, United States of America), N. Fitch (Maasmechelen, Belgium), B. Thornton (Kenilworth, New Jersey, United States of America), P. Sterk (Amsterdam, Netherlands), R. Lutter And The U-Biopred Study Group (Amsterdam, Netherlands). Rhinovirus Challenge in Asthmatics and Healthy Volunteers to Evaluate the Safety and Appropriate Dose of a GMP Human Rhinovirus 16 Preparation for Challenge Studies in Mild-Moderate Asthmatics taking ICS. 4406

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

• The Relationship Between Functional Status and Fatigue After COVID-19 Infection
• Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
• Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency